JTB and breast cancer: Another study based on in-solution proteomics conducted by Jayathirtha et al. (2022) also highlighted that JTB dysregulation, either overexpression or downregulation, in the MCF7 BC cell line significantly alters key biological processes, including EMT, cytoskeleton organization, metabolic reprogramming, and cellular proteostasis [15].